---

$0.60

-0.0199 ( -3.21% ) 682.1K

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-08-19	Buy	794.00	Finney Kevin
2025-07-31	Buy	10000.00	Watson W. Mark
2025-05-19	Buy	100000.00	Lo Steven
2024-06-20	Buy	20000.00	Watson W. Mark
2024-06-13	Sale	-2007.00	Lee Phillip E
2024-06-12	Sale	-16000.00	HERON ELAINE J
2024-06-12	Sale	-16000.00	Watson W. Mark
2024-06-12	Sale	-16000.00	Yedid Robert A.
2024-06-12	Sale	-16000.00	Wheadon David E.
2024-06-12	Sale	-16000.00	Finney Michael J.